X-ray Fluorescence and the Pharmaceutical Industry: Implementing an Age-Old Technique
Wavelength-dispersive X-ray fluorescence (WDXRF) is a direct analysis technique for the detection and quantification of elements/composition and elemental impurities in pharmaceuticals. It can also analyze a final product as unadulterated pills in a non-destructive analysis. What follows is a dedicated dialog between Spectroscopy and two of Rigaku’s top XRF experts.
SPECTROSCOPY: Can you tell us more about the roles you are currently in at Rigaku?
WILLIAMS: We are both applications scientists specializing in XRF. Essentially, we find the best way to prepare and analyze a sample and make methods for customers who are evaluating a system or existing customers who have a system and have different samples they want to look at. We have customers in almost every field, and there are many cases in which XRF can benefit the development, control, and design of products. Pharmaceuticals is one area we want to expand into.
NGUYEN: Within the last few years, Glenn and I have been working on a variety of different pharmaceutical-related applications.
Read More > |